Picture of Elicera Therapeutics AB logo

ELIC Elicera Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Elicera Enters Agreement With Prominent US Cancer Center

March 6 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ENTERS AGREEMENT WITH PROMINENT US CANCER CENTER TO
EVALUATE THE
USE OF ITANK IN T-CELL RECEPTOR THERAPIES

Source text for Eikon:  ID:nWkr1SBYFG 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Elicera Therapeutics AB

See all news